Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China flag China · Delayed Price · Currency is CNY
23.44
+0.64 (2.81%)
Sep 2, 2026, 3:00 PM CST

SHA:605177 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
255.03243.97513.18711.12501.58556.1
Short-Term Investments
-84.9317.83177.9--
Trading Asset Securities
6012050-3050
Cash & Short-Term Investments
315.03448.89581.01889.03531.58606.1
Cash Growth
-34.57%-22.74%-34.65%67.24%-12.29%-38.74%
Accounts Receivable
140.2184.79178.1209.59159.39128.89
Other Receivables
2.746.534.761.451.421.65
Receivables
142.94191.33182.85211.03160.81130.54
Inventory
414.52537.18720.57621.06482.84419.33
Prepaid Expenses
----1.08-
Other Current Assets
103.916.0544.5225.9412.4216.45
Total Current Assets
976.391,1931,5291,7471,1891,172
Property, Plant & Equipment
1,8261,9001,7441,3521,011834.88
Long-Term Investments
49.9280.69148.28150.64181.4610
Other Intangible Assets
68.0859.8760.0661.8562.9745.15
Long-Term Deferred Tax Assets
64.9250.832.8912.5312.910.52
Long-Term Deferred Charges
5051.7333.9410.824.313.89
Other Long-Term Assets
32.771.748.098.5910.5174.21
Total Assets
3,0683,3383,5573,3432,4722,251

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
307.58369.77731.77520.12411.09406.25
Accrued Expenses
23.5445.9437.2740.8337.0224.65
Short-Term Debt
106.52228.6298.94120.0795.01-
Current Portion of Long-Term Debt
26.283.779.1-0.02-
Current Portion of Leases
-2.912.983.823.63-
Current Income Taxes Payable
6.695.7606.799.493.64
Current Unearned Revenue
12.7211.9410.363.238.419.41
Other Current Liabilities
12.4622.1923.133.195.025.34
Total Current Liabilities
495.79690.89913.55698.05569.69449.29
Long-Term Debt
782.78752.33677.24576.4315-
Long-Term Leases
6.056.574.86.629.12.38
Long-Term Unearned Revenue
79.4881.8785.8446.236.7140.47
Long-Term Deferred Tax Liabilities
--0.160.460.67-
Other Long-Term Liabilities
0.540.330.270.320.790.85
Total Liabilities
1,3651,5321,6821,328631.95492.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
114.72114.73114.75113.6113.6113.6
Additional Paid-In Capital
1,1351,1301,1181,1291,1291,129
Retained Earnings
348.29466.67549.06686.3597.99516.31
Treasury Stock
-10.11-20.29-20.55-30--
Comprehensive Income & Other
115.69114.73113.18116.72-0.48-0.48
Total Common Equity
1,7031,8061,8752,0151,8401,758
Minority Interest
--0.12---
Shareholders' Equity
1,7031,8061,8752,0151,8401,758
Total Liabilities & Equity
3,0683,3383,5573,3432,4722,251

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
921.63994.2793.06706.93122.762.38
Net Cash (Debt)
-606.6-545.31-212.05182.1408.82603.72
Net Cash Growth
----55.46%-32.28%-38.36%
Net Cash Per Share
-5.33-4.77-1.901.463.605.29
Filing Date Shares Outstanding
116.3112.93108.61111.43113.6113.6
Total Common Shares Outstanding
116.3112.93108.61112.58113.6113.6
Working Capital
480.61502.56615.41,049619.04723.13
Book Value Per Share
14.6515.9917.2617.9016.2015.48
Tangible Book Value
1,6351,7461,8151,9531,7771,713
Tangible Book Value Per Share
14.0615.4616.7117.3515.6415.08
Buildings
-1,126632.03545.94454.64410.59
Machinery
-1,4061,1891,084878.92723.64
Construction In Progress
-170.74599.8296.55157.09114.87